1) Describe the CDC 2022 Clinical Practice Guidelines for prescribing opioids for pain, including recommendations for non-opioid therapy, dosage determination, and tapering strategies.

2) Differentiate between opioid and non-opioid options in multimodal pain management, including their mechanisms, benefits, and potential risks.

3) Apply evidence-based risk mitigation strategies—such as ILPMP review and naloxone co-prescribing—to optimize patient safety and reduce opioid-related harm.

Session date: 
11/19/2025 - 8:00am to 9:00am CST
Location: 
Schwab Rehabilitation Hospital
1401 S. California Ave.
4th Fl. Conf. Rm.
Chicago, IL 60608
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Zibin Zhang, PharmD